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Abstract
Trace amine-associated receptors were discovered from a search for novel 5-HT receptors [9], where 15
mammalian orthologues were identified and divided into two families. The TA1 receptor (nomenclature as
agreed by the NC-IUPHAR Subcommittee for the Trace amine receptor [53]) has affinity for the endogenous
trace amines tyramine, β-phenylethylamine and octopamine in addition to the classical amine dopamine [9].
Emerging evidence suggests that TA1 is a modulator of monoaminergic activity in the brain [90] with TA1 and
dopamine D2 receptors shown to form constitutive heterodimers when co-expressed [28]. In addition to trace
amines, receptors can be activated by amphetamine-like psychostimulants, and endogenous thyronamines.
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